← All peptide guidesManchester Peptides gold M logo

Peptides explained

hMG: how it works

Also known as: Menotrophin / human menopausal gonadotrophin

Page updated · Sources and editorial approach

hMG explained: FSH and LH biological activity, reproductive hormone pathways and the importance of monitored, product-specific fertility treatment.

hMG at a glance

What it does biologically

Menotrophin provides FSH and LH biological activity, involved in reproductive function.

What the evidence shows

Authorised medicines have defined fertility indications and require clinical monitoring.

What remains uncertain

Those indications do not establish general hormone optimisation or performance benefits.

The basics

What is hMG?

hMG stands for human menopausal gonadotrophin. Menotrophin is a preparation providing follicle-stimulating hormone and luteinising-hormone biological activity.

Composition is more specific than the abbreviation suggests. For example, the Menopur product information explains that hCG can contribute to the preparation's LH activity. Product documentation matters.

Biological action

How does hMG work?

FSH-related activity supports follicular development in ovarian physiology and has a role in Sertoli-cell function in the testes. LH-related activity supports reproductive steroid signalling.

These pathways require a clinical diagnosis and monitoring. hMG, hCG and recombinant FSH are different preparations rather than interchangeable hormone boosters.

Questions being investigated

What do studies examine?

Fertility care

The authorised medicine is assessed for specified reproductive indications.

Hormone bioactivity

International units describe measured biological activity and cannot simply be read as milligrams.

Monitoring

Response and adverse effects require professional assessment.

Strength of evidence

How strong is the evidence?

Evidence is separated by level because a cell experiment, an animal model, a human trial and a regulatory decision answer different questions.

Evidence for hMG, separated by study type
Evidence typeWhat it tells us
LaboratoryFSH- and LH-related biological actions are established.
AnimalAnimal findings do not establish broad wellness claims.
HumanProduct-specific clinical evidence supports defined fertility uses.
RegulatoryMenotrophin is a prescription medicine; its indication is not a general enhancement claim.

Important context

Risks, limitations and unanswered questions

  • Ovarian hyperstimulation and multiple-pregnancy risks are part of clinical decision-making.
  • Different preparations cannot be substituted on an abbreviation alone.
  • The full clinical context matters more than a single hormone measurement.

Reading the original evidence

Read gonadotrophin activity and the medicine name together

The Menopur product information describes menotrophin with FSH and LH activity in defined fertility indications. Hormone activity and its clinical interpretation depend on the exact medicine and context. A similarly named preparation is not validated by copying information from that label.

Question to take to the source: Does the claim preserve the medicine, its stated biological activity and the clinical setting?

Check the original source ↗

For personal accounts and research questionnaires, read user feedback and patient-reported outcomes.

Detailed catalogue research

hMG menotrophin research: FSH and LH activity in fertility care

Understand what hMG means, how it differs from hCG and how clinical evidence describes monitored fertility outcomes.

What is hMG and what do FSH and LH activity mean?

Human menopausal gonadotrophin, or hMG, refers to a preparation with follicle-stimulating hormone and luteinising hormone biological activity. The product-specific description matters. The label is a statement about biological activity, and the different units should not be treated as a simple mass or as evidence that a differently named hormone has the same effects.

What is the difference between hMG, hCG and recombinant FSH?

hMG supplies specified gonadotrophin activities. hCG activates the LH/CG receptor, while recombinant FSH is a defined preparation with FSH activity. The Menopur prescribing information explains that hCG can contribute to its measured LH activity. That composition detail does not make hMG and hCG interchangeable. Trials have to identify the formulation used.

What outcomes do menotrophin fertility studies measure?

A study may measure follicular response, the number of oocytes collected or pregnancy. These are different outcomes and reflect a broader treatment pathway, not just a single medicine. Compare like outcomes from similar patient groups and read the monitoring and adverse-event information. Ovarian hyperstimulation and multiple pregnancy are among the risks addressed in the prescribing information.

Sources for this research section

Browse the other catalogue research guides →

Questions answered

hMG FAQs

Is hMG a single short peptide?

No. It is a gonadotrophin preparation with specified hormonal biological activity.

Is hMG the same as hCG?

No. hMG provides FSH and LH activity, while hCG has a different identity and receptor-related role.

Check the sources

Sources and further reading

Follow the original study or official information to check the population, methods and full results. Reviews and sponsor updates are labelled below.

  1. Menopur UK product information ↗Authorised composition, mechanism, indications and safety information.
  2. Menopur patient leaflet ↗Product-specific patient information; not a general-purpose hormone guide.

Educational information, prepared with AI assistance and not independently clinically reviewed. It is not personal medical advice or a treatment recommendation. Read the editorial policy or suggest a correction.

Reviews